Please assess the completion status of the following clinical trial:

Trial Title: Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Constitutional delay of growth and puberty~* Age 14 years or more~* mean testicular volume 2.5 ml or more and less than 4 ml~* serum testosterone level less than 5 nM OR~as above, but serum testosterone 1 nM or more with normal DHEAS level, even if the mean testicular volume is less than 2.5 ml OR~as above, but tanner stage G2 and testosterone level less than 3 nM~Exclusion Criteria:~* Chronic diseases~* Primary or secondary hypogonadism~* Chromosomal anomalies~* Chronic medication that potentially adversely affects bone mineralization (excluding inhaled corticosteroid treatment)

- Gender: MALE
- Minimum Age: 14 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Testosterone (Type: ACTIVE_COMPARATOR): \~1mg/kg every 4 weeks for 6 months
- Letrozole (Type: ACTIVE_COMPARATOR): 2.5mg daily for 6 months

Based on this trial design, predict the completion outcome and termination type (if applicable).